Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 1-Year Low at $268.24

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as $268.24 and last traded at $268.88, with a volume of 42 shares. The stock had previously closed at $283.45.

Bio-Rad Laboratories Trading Down 5.1 %

The company has a debt-to-equity ratio of 0.13, a current ratio of 6.57 and a quick ratio of 4.89. The company has a market capitalization of $7.67 billion, a P/E ratio of -27.36 and a beta of 0.72. The firm has a fifty day moving average price of $281.80 and a 200-day moving average price of $310.14.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $2.29 earnings per share (EPS) for the quarter. The firm had revenue of $610.82 million during the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.